PDL BioPharma 8-K 2012
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 17, 2012
PDL BioPharma, Inc.
(Exact name of Company as specified in its charter)
(Commission File Number)
932 Southwood Boulevard
Incline Village, Nevada 89451
(Address of principal executive offices, with zip code)
(Company’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:
Item 1.01 Entry into a Material Definitive Agreement.
On April 17, 2012, PDL BioPharma, Inc. (the Company) entered into a lease agreement with 932936, LLC, with respect to the leasing of its headquarters located in Incline Village, Nevada (the Lease). The Lease commences on June 1, 2012, and expires on May 31, 2014, and is for approximately 4,812 square feet of office space. The fixed monthly rent under the Lease through expiration is $14,176.10. The lease is a triple net lease, with the Company responsible for taxes, insurance and maintenance (including snow removal) for the portion of the property leased by the Company. The Company may, at its option, extend the term of the Lease for an additional two years for a 2% increase to its monthly rent.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: April 20, 2012